home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Structured Product Labeling XML Composition: Enhancing the US Drug Patient Information Process

 
  June 21, 2023  
     
 
Xtalks, online
2023 -7-13


Preparing patient and public-facing US drug product information has multiple challenges including the absolute requirement for an accurate representation of the US Food and Drug Administration (FDA) approved text and flowing content into multiple output formats for electronic, web and paper distribution. Working within the FDA regulatory regulations, many drug manufacturers have multiple process steps using internal and external resources to generate messaging for users (healthcare providers, patients) and for promotional advertising including web-based and printed materials. Providing these materials facilitates the drug product presence in the marketplace and in some cases is an FDA requirement. In this webinar, the featured speaker will explore the utilization of the structured product labeling XML format for providing drug-related information to patients.
 
This webinar will look at the basic regulatory and business composition and publishing requirements, with a specific focus on the structured product labeling XML composition. In addition, they will summarize an alternative process that is inherently more accurate and faster than traditional processing methods using state of the art tools.
 
 
Organized by: Xtalks
Invited Speakers: Gary Saner, Sr. Manager, Information Solutions Life Sciences, Reed Tech
 
Deadline for Abstracts: 2023 -7-13
 
Registration: Free registration
E-mail: ajuurinen@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.